Reset filter
Keywords
Dermatology ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

134 Search results.

Relevance Rating New first Old first

DLQI - Dermatology Life Quality Index (DLQI)

- 9/7/16 - 1 form, 1 itemgroup, 12 items, 17 languages
Itemgroup: Skin problems past week
Details and Conditions of Use see: Finlay A.Y., Khan G.K. Dermatology Life Quality Index (DLQI) - A simple practical measure for routine clinical use. Clinical and Experimental Derm 1994; 19:210-16 Used as routine documentation at the University Hospital in Muenster (UKM).

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - IMD Report - Rheumatic Diseases; Systemic Lupus Erythematosus or Cutaneous Lupus; Sjogren's Syndrome (Report Final and Annex Report 2 Final)

- 11/2/20 - 1 form, 25 itemgroups, 95 items, 1 language
Itemgroups: Administrative,Rheumatic Diseases,Rheumatic Diseases - Signs and Symptoms,Rheumatic diseases - Other signs and symptoms,Rheumatic diseases - Other signs and symptoms ,Rheumatic diseases - Diagnostic Test Results,Rheumatic diseases - Other Diagnostic Test Results ,Rheumatic diseases - Other Diagnostic Test Results ,Rheumatic diseases - Other diagnostic Procedure,Systemic Lupus Erythematosus or Cutaneous Lupus,Systemic Lupus Erythematosus or Cutaneous Lupus - Signs and symptoms (supporting the final diagnosis),Systemic Lupus Erythematosus or Cutaneous Lupus - Other Signs and symptoms,Systemic Lupus Erythematosus or Cutaneous Lupus - Other Signs and symptoms ,Systemic Lupus Erythematosus or Cutaneous Lupus - Diagnostic Test Results,Systemic Lupus Erythematosus or Cutaneous Lupus - Other Diagnostic Test Results ,Systemic Lupus Erythematosus or Cutaneous Lupus - Other Diagnostic Test Results ,Systemic Lupus Erythematosus or Cutaneous Lupus - Other diagnostic Procedure ,Sjogren's Syndrome,Sjogren's Syndrome - Signs and symptoms (supporting the final diagnosis),Sjogren's Syndrome - Other Signs and symptoms ,Sjogren's Syndrome - Other Signs and symptoms ,Sjogren's Syndrome - Diagnostic Test Results ,Sjogren's Syndrome - Other Diagnostic Test Results ,Sjogren's Syndrome - Other Diagnostic Test Results ,Sjogren's Syndrome - Other diagnostic Procedure
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Screening Visit 1 Psoriasis NCT02695940

- 9/27/21 - 1 form, 10 itemgroups, 62 items, 1 language
Itemgroups: Administrative data,Eligibility criteria,Demography,Medical History,Treated body regions,Vital signs,ECG,Blood sample,Urine sample,miscellaneous
NCT02695940 A Phase 2a, Proof of Concept Trial, Testing Twice Daily Application of LEO 124249 Ointment 30 mg/g in the Treatment of Mild to Moderate Inverse Psoriasis. Quelle: Prof. Dr. Dr. h.c. Thomas Luger University Hospital of Muenster Department of Dermatology

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - Screening - Primary Tumor Characteristics; Regional Lymph Node Status; Tumor Sample (Annex Report 2 Final Annex Report 2 Final)

- 9/20/21 - 1 form, 4 itemgroups, 27 items, 1 language
Itemgroups: Administrative,Primary Tumor Characteristics,Regional Lymph Node Status,Tumor Sample
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Dekurs HAUT Infusion MS University Hospital Muenster (UKM)

- 9/20/21 - 1 form, 5 itemgroups, 20 items, 1 language
Itemgroups: Diagnosis,Last Examinations,Physician's Documentation,Nursing Documentation,Comments
Hospital Routine Documentation Form at the University Hospital Muenster. Original Form name: Dekurs HAUT Infusion.

Eligibility NCT00980629 Atopic Dermatitis - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 19 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00980629

Eligibility NCT00777127 Actinic Keratosis - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 26 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00777127

Eligibility NCT00757523 Acne Vulgaris - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 24 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00757523

Eligibility NCT00408187 Psoriasis - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 30 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00408187

Eligibility NCT00445081 Atopic Dermatitis - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 32 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00445081

Eligibility NCT00669708 Compensate the Roughness of the Skin - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 9 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00669708

Eligibility NCT00606450 Psoriasis - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 24 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00606450

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial